Keyphrases
Triglycerides
100%
High-density Lipoprotein Cholesterol (HDL-C)
100%
Statins
100%
Lipid Parameters
100%
Mixed Dyslipidemia
100%
Fenofibric Acid
100%
Moderate Dose
83%
Low-density Lipoprotein Cholesterol (LDL-C)
50%
Monotherapy
33%
Combination Treatment
33%
Dose Combination
33%
High-dose Statin
33%
Treatment Options
16%
Safety Profile
16%
Paucity
16%
Randomized Clinical Trial
16%
Lipid Abnormalities
16%
Safety Analysis
16%
Fibrates
16%
Component Therapy
16%
Efficacy Analysis
16%
Statin Therapy
16%
Low-dose Combination
16%
Low-dose Statin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Dyslipidemia
100%
Triacylglycerol
100%
High Density Lipoprotein Cholesterol
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Fenofibric Acid
100%
Statin (Protein)
66%
Low Density Lipoprotein Cholesterol
50%
Monotherapy
33%
Randomized Clinical Trial
16%
Fibric Acid Derivative
16%